James Basta, EVP, General Counsel at Intellia Therapeutics, Inc. (NTLA), sold 2,572 shares at $8.99 ($23K) on 2025-03-04, disclosed to the SEC on 2025-03-04.
Seasonal sale ($23k) by EVP, General Counsel — this insider has traded NTLA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| NTLA | SELL | 2025-01-07 | $172K | — | Filing → |
| NTLA | SELL | 2024-03-05 | $152K | — | Filing → |
| NTLA | SELL | 2024-01-05 | $224K | — | Filing → |